Sign in
4

Changes in Ownership

NewAmsterdam Pharma Co N.V. Filed Acc 0000950170-25-002363

Options or other derivatives

  • Chief Commercial Officer acquired 200,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

JONES WILLIAM A JR · Chief Commercial Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-01-02 Grant or award : show line 1 in the form Option (right to buy) +200,000 200,000 D
Loading xslF345X05/ownership.xml…